Thermo Fisher to Offer Senior Notes | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today filed a registration statement with the US Securities and Exchange Commission to offer senior notes to fund its acquisition of Dionex, as well as for general corporate purposes.

Details of the offering have yet to be determined, including the total amount Thermo Fisher is seeking to raise, other than the firm's intention offer three sets of senior notes due 2014, 2016, and 2021, respectively.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.